315 related articles for article (PubMed ID: 16134300)
21. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
[TBL] [Abstract][Full Text] [Related]
22. Clinical and genetic aspects of neurofibromatosis 1.
Jett K; Friedman JM
Genet Med; 2010 Jan; 12(1):1-11. PubMed ID: 20027112
[TBL] [Abstract][Full Text] [Related]
23. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
24. Fatal Retroperitoneal Bleeding in Neurofibromatosis Type 1: A Clinically Occult Complication.
Voudouri M; Chambers M; Baker ML; Kerr DA
Am J Forensic Med Pathol; 2023 Mar; 44(1):63-67. PubMed ID: 36398883
[TBL] [Abstract][Full Text] [Related]
25. Unidentified bright objects associated with features of neurofibromatosis 1.
Szudek J; Friedman JM
Pediatr Neurol; 2002 Aug; 27(2):123-7. PubMed ID: 12213613
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis type 1: a diagnostic mimicker at CT.
Fortman BJ; Kuszyk BS; Urban BA; Fishman EK
Radiographics; 2001; 21(3):601-12. PubMed ID: 11353109
[TBL] [Abstract][Full Text] [Related]
27. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
28. [Von Recklinghausen's disease: experimental models and comparative aspects].
Turusov VS; Kardeza A; Ribal'ta T
Arkh Patol; 1996; 58(5):3-13. PubMed ID: 9005821
[TBL] [Abstract][Full Text] [Related]
29. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
Bikowska-Opalach B; Jackowska T
Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
[TBL] [Abstract][Full Text] [Related]
30. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
[TBL] [Abstract][Full Text] [Related]
32. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1.
Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C
J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150
[TBL] [Abstract][Full Text] [Related]
34. Deep-seated segmental neurofibromatosis without café au lait spots.
Ogose A; Hotta T; Imaizumi S; Saito H; Homma T; Takahashi HE
Skeletal Radiol; 2000 Sep; 29(9):543-7. PubMed ID: 11000302
[TBL] [Abstract][Full Text] [Related]
35. [Syndromes 18. Von Recklinghausen's disease].
Baart JA; van Hagen JM
Ned Tijdschr Tandheelkd; 2000 Feb; 107(2):57-9. PubMed ID: 11385791
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis-I Presentating with Multiple Spinal and Intracranial Neurofibromas.
Tripathi S; Pandey CB; Dubey TN; Singh P
J Assoc Physicians India; 2016 Feb; 64(2):72-74. PubMed ID: 27730789
[TBL] [Abstract][Full Text] [Related]
37. Orthopaedic manifestations of neurofibromatosis type 1: A case report.
Năstase F; Radaschin DS; Niculeț E; Brădeanu AV; Verenca MC; Nechita A; Chioncel V; Nwabudike LC; Baroiu L; Drima Polea E; Fotea S; Anghel L; Nechifor A; Tatu AL
Exp Ther Med; 2022 Feb; 23(2):135. PubMed ID: 35069816
[TBL] [Abstract][Full Text] [Related]
38. Association of urticaria pigmentosa with café-au-lait spots, neurofibromas and neurofibroma-like neoplasms: a mere coincidence?
Möhrenschlager M; Engst R; Müller-Weihrich S; Spiessl W; Rüdisser K; Weigl LB; Jessberger B; Braun-Falco M; Abeck D; Ring J
Dermatology; 2003; 206(4):297-302. PubMed ID: 12771469
[TBL] [Abstract][Full Text] [Related]
39. Manifestations of the tongue in Neurofibromatosis type 1.
Bongiorno MR; Pistone G; Aricò M
Oral Dis; 2006 Mar; 12(2):125-9. PubMed ID: 16476032
[TBL] [Abstract][Full Text] [Related]
40. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
